Protocol detail

HER2-Positive Breast Cancer Treatement Outcomes

Protocol full text hidden due to copyright restrictions

However, the full text is available at the following link: Access Free Full Text.

Yuan J.Q., Wang S.M, & Guo L. (2023). S100A9 promotes glycolytic activity in HER2-positive breast cancer to induce immunosuppression in the tumour microenvironment. Heliyon, 9(2), e13294.

Publication 2023

Adjuvant Axillary Breast Breast conserving surgery Breast surgery Breast tumors Cancer of the breast Carboplatin Chemotherapy Core needle biopsy Fluorescence in situ hybridisation Her2 Hospital ethics committee Immunohistochemistry Inflammatory breast cancer Lymph node dissection Lymph node metastasis Lymph nodes Lymph vascular Mastectomy Menopause Metastasis disease Modified radical mastectomy Patients Preservation Radiation therapy Recurrence Sentinel lymph node biopsy Surgery Taxane Therapy Trastuzumab

Corresponding Organization : Central South University

Top 5 similar protocols

Variable analysis

Dependent Variables detection not available due to copyright restrictions.
Unable to provide accurate variables.

Annotations

Annotations not available due to copyright restrictions

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!